Both the classical and alternative non-homologous end joining pathways contribute to the fusion of drastically shortened telomeres induced by TRF2 overexpression

Bernadette Nera, Hui Shun Huang, Eric A Hendrickson, Lifeng Xu

Research output: Contribution to journalArticle

Abstract

The double-stranded telomeric binding protein TRF2 is expressed in many human cancers at elevated levels. Moreover, experimental overexpression of TRF2 in human cells causes replication stalling in telomeric tracts, which leads to drastic telomere shortening and fusion of deprotected chromosome ends. To understand which end joining pathway is involved in mediating these chromosome fusions, we overexpressed TRF2 in human HCT116 cell lines that were deficient for the DNA Ligase 4 (Lig4)-dependent classical non-homologous end joining (C-NHEJ) or the DNA Ligase 3 (Lig3)-dependent alternative non-homologous end joining (A-NHEJ) pathway. Surprisingly, abrogation of either Lig4 or nuclear Lig3 significantly reduced inter-chromosomal fusion of drastically shortened telomeres, suggesting that both the C-NHEJ and A-NHEJ pathways are involved in mediating this type of fusion. Fusion between deprotected sister chromatids, however, only required the Lig3-dependent A-NHEJ pathway. Interestingly, a previous study reported similar end joining pathway requirements for the fusion of critically shortened telomeres during a telomere attrition-based cellular crisis. We speculate that, as in cellular crisis, the same repair pathway(s) may drive clonal and genomic evolution in human cancers containing elevated TRF2 levels.

Original languageEnglish (US)
Pages (from-to)880-888
Number of pages9
JournalCell Cycle
Volume18
Issue number8
DOIs
StatePublished - Apr 18 2019

Fingerprint

Telomere Shortening
Ligases
DNA Ligases
Telomere-Binding Proteins
Chromosomes
Clonal Evolution
HCT116 Cells
Chromatids
Telomere
Neoplasms
Cell Line

Keywords

  • drastic telomere shortening
  • inter-chromosomal fusions
  • Lig3-dependent A-NHEJ
  • Lig4-dependent C-NHEJ
  • sister chromatid fusions
  • TRF2 overexpression

PubMed: MeSH publication types

  • Journal Article

Cite this

Both the classical and alternative non-homologous end joining pathways contribute to the fusion of drastically shortened telomeres induced by TRF2 overexpression. / Nera, Bernadette; Huang, Hui Shun; Hendrickson, Eric A; Xu, Lifeng.

In: Cell Cycle, Vol. 18, No. 8, 18.04.2019, p. 880-888.

Research output: Contribution to journalArticle

@article{40e958a746484bd39707b7214b2f0666,
title = "Both the classical and alternative non-homologous end joining pathways contribute to the fusion of drastically shortened telomeres induced by TRF2 overexpression",
abstract = "The double-stranded telomeric binding protein TRF2 is expressed in many human cancers at elevated levels. Moreover, experimental overexpression of TRF2 in human cells causes replication stalling in telomeric tracts, which leads to drastic telomere shortening and fusion of deprotected chromosome ends. To understand which end joining pathway is involved in mediating these chromosome fusions, we overexpressed TRF2 in human HCT116 cell lines that were deficient for the DNA Ligase 4 (Lig4)-dependent classical non-homologous end joining (C-NHEJ) or the DNA Ligase 3 (Lig3)-dependent alternative non-homologous end joining (A-NHEJ) pathway. Surprisingly, abrogation of either Lig4 or nuclear Lig3 significantly reduced inter-chromosomal fusion of drastically shortened telomeres, suggesting that both the C-NHEJ and A-NHEJ pathways are involved in mediating this type of fusion. Fusion between deprotected sister chromatids, however, only required the Lig3-dependent A-NHEJ pathway. Interestingly, a previous study reported similar end joining pathway requirements for the fusion of critically shortened telomeres during a telomere attrition-based cellular crisis. We speculate that, as in cellular crisis, the same repair pathway(s) may drive clonal and genomic evolution in human cancers containing elevated TRF2 levels.",
keywords = "drastic telomere shortening, inter-chromosomal fusions, Lig3-dependent A-NHEJ, Lig4-dependent C-NHEJ, sister chromatid fusions, TRF2 overexpression",
author = "Bernadette Nera and Huang, {Hui Shun} and Hendrickson, {Eric A} and Lifeng Xu",
year = "2019",
month = "4",
day = "18",
doi = "10.1080/15384101.2019.1598724",
language = "English (US)",
volume = "18",
pages = "880--888",
journal = "Cell Cycle",
issn = "1538-4101",
publisher = "Landes Bioscience",
number = "8",

}

TY - JOUR

T1 - Both the classical and alternative non-homologous end joining pathways contribute to the fusion of drastically shortened telomeres induced by TRF2 overexpression

AU - Nera, Bernadette

AU - Huang, Hui Shun

AU - Hendrickson, Eric A

AU - Xu, Lifeng

PY - 2019/4/18

Y1 - 2019/4/18

N2 - The double-stranded telomeric binding protein TRF2 is expressed in many human cancers at elevated levels. Moreover, experimental overexpression of TRF2 in human cells causes replication stalling in telomeric tracts, which leads to drastic telomere shortening and fusion of deprotected chromosome ends. To understand which end joining pathway is involved in mediating these chromosome fusions, we overexpressed TRF2 in human HCT116 cell lines that were deficient for the DNA Ligase 4 (Lig4)-dependent classical non-homologous end joining (C-NHEJ) or the DNA Ligase 3 (Lig3)-dependent alternative non-homologous end joining (A-NHEJ) pathway. Surprisingly, abrogation of either Lig4 or nuclear Lig3 significantly reduced inter-chromosomal fusion of drastically shortened telomeres, suggesting that both the C-NHEJ and A-NHEJ pathways are involved in mediating this type of fusion. Fusion between deprotected sister chromatids, however, only required the Lig3-dependent A-NHEJ pathway. Interestingly, a previous study reported similar end joining pathway requirements for the fusion of critically shortened telomeres during a telomere attrition-based cellular crisis. We speculate that, as in cellular crisis, the same repair pathway(s) may drive clonal and genomic evolution in human cancers containing elevated TRF2 levels.

AB - The double-stranded telomeric binding protein TRF2 is expressed in many human cancers at elevated levels. Moreover, experimental overexpression of TRF2 in human cells causes replication stalling in telomeric tracts, which leads to drastic telomere shortening and fusion of deprotected chromosome ends. To understand which end joining pathway is involved in mediating these chromosome fusions, we overexpressed TRF2 in human HCT116 cell lines that were deficient for the DNA Ligase 4 (Lig4)-dependent classical non-homologous end joining (C-NHEJ) or the DNA Ligase 3 (Lig3)-dependent alternative non-homologous end joining (A-NHEJ) pathway. Surprisingly, abrogation of either Lig4 or nuclear Lig3 significantly reduced inter-chromosomal fusion of drastically shortened telomeres, suggesting that both the C-NHEJ and A-NHEJ pathways are involved in mediating this type of fusion. Fusion between deprotected sister chromatids, however, only required the Lig3-dependent A-NHEJ pathway. Interestingly, a previous study reported similar end joining pathway requirements for the fusion of critically shortened telomeres during a telomere attrition-based cellular crisis. We speculate that, as in cellular crisis, the same repair pathway(s) may drive clonal and genomic evolution in human cancers containing elevated TRF2 levels.

KW - drastic telomere shortening

KW - inter-chromosomal fusions

KW - Lig3-dependent A-NHEJ

KW - Lig4-dependent C-NHEJ

KW - sister chromatid fusions

KW - TRF2 overexpression

UR - http://www.scopus.com/inward/record.url?scp=85063950749&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85063950749&partnerID=8YFLogxK

U2 - 10.1080/15384101.2019.1598724

DO - 10.1080/15384101.2019.1598724

M3 - Article

VL - 18

SP - 880

EP - 888

JO - Cell Cycle

JF - Cell Cycle

SN - 1538-4101

IS - 8

ER -